ORIGINAL RESEARCH

Evaluation of cardiac MRI efficacy in the diagnosis of hibernating myocardium

Rustamova YK1, Imanov GG2, Azizov VA1
About authors

1 Department of Internal Diseases No 2, Azerbaijan Medical University, Baku, Azerbaijan

2 Department of Internal Diseases No 1, Azerbaijan Medical University, Baku, Azerbaijan

Correspondence should be addressed: Yasmin K. Rustamova
Bakikhanova 23, Baku, Azerbaijan, AZ1022; moc.liamg@tsr.nimsay

Received: 2018-01-16 Accepted: 2018-06-20 Published online: 2018-09-17
|
  1. Kwon DH, Hachamocitch R, Popovic ZB. et al. Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with endsystolic volume and viability. Circulation. 2012; (126): 3–8.
  2. Ryzhkova DV, Kostina IS. Magnitno-rezonansnaja i pozitronnojemissionnaja tomografija serdca v prognozirovanii obratimosti lokal'noj funkcii levogo zheludochka u bol'nyh s hronicheskimi okkljuzijami koronarnyh arterij. Rossijskij kardiologicheskij zhurnal. 2014; 2 (106): 72–8.
  3. Camici PG, Kumak SP, Rimoldi OE. Stunning, Hybernating and Assesment of Myocardial Viability. Circulation. 2008; (117): 103– 14.
  4. Nagel E, Schuster A. Shortening without contraction: new insights into hibernating myocardium. J Am Coll Cardiol Img. 2010; (3): 731–33.
  5. Alehin MN, Bozhev AM, Morozova JuA i dr. Stress-jehokardiografija s dobutaminom v diagnostike zhiznesposobnosti u bol'nyh s revaskuljarizaciej miokarda. Kardiologija. 2000; (12): 44–9.
  6. Ling LH, Marvick TH, Flores DR, et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013; (6): 363–72.
  7. Hickman M, Chelliah R, Burden L, Senior R. Resting myocardial blood flow, coronary flow reserve, and contractile reserve in hibernating myocardium: implications for using resting myocardial contrast echocardiography vs. dobutamine echocardiography for the detection of hibernating myocardium. Eur J Echocardiogr. 2010; (119): 756–62.
  8. Usov VJu, Arhangelskij VA, Fedorenko EV. Ocenka zhiznesposobnosti povrezhdennogo miokarda u kardiohirurgicheskih bol'nyh: sravnenie vozmozhnostej magnitnorezonansnoj i jemissionnoj tomografii. Kompleksnye problemy serdechno – sosudistyh zabolevanij. 2014; (3): 124–33.
  9. Arai AE. The cardiac magnetic resonance approach to assessing myocardial viability. J Nucl Cardiol. 2011; 18 (6): 1095–102.
  10. Trufanov GE, Rud SD, Zheleznjak SE. MRT v diagnostike ishemicheskoj bolezni serdca: uchebnoe posobie. SPb.: ЕLBISPb; 2012. 63 s.
  11. Kokov A. N., Masenko V. L., Semenov S. E., Barbarash O. L MRT serdca v ocenke postinfarktnyh izmenenij i ee rol' v opredelenii taktiki revaskuljarizacii miokarda. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2014; (3): 97–102.
  12. Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010; (121): 692–705.
  13. West AM, Kramer CM. Cardiovascular magnetic resonance imaging of myocardial infarction, viability and cardiomyopathies. Curr Probl Cardiol. 2010; (35): 176–220.
  14. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014; (35): 2541–619.
  15. Kramer CM, Schulz-Menger J, Bluemke DA. et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustee’s task force on standardized protocols. J Cardiovasc Magn Reson. 2013; 15 (1): 35.